Physician Wealth Advisors’s Sana Biotechnology SANA Stock Holding History

Physician Wealth Advisors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.4K	Hold	975	–	–	﹤0.01%	1271
2026 Q1	$2.81K	Hold	975	–	–	﹤0.01%	1206
2025 Q4	$3.97K	Hold	975	–	–	﹤0.01%	1051
2025 Q3	$3.46K	Hold	975	–	–	﹤0.01%	1033
2025 Q2	$2.66K	Buy	975 +565	+138%	+$1.17K	﹤0.01%	954
2025 Q1	$689	Hold	410	–	–	﹤0.01%	1280
2024 Q4	$669	Buy	+410	New	+$1.22K	﹤0.01%	1060

Other funds holding SANA

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

VCM

Viewpoint Capital Management Seattle, Washington $196M AUM 32.97% 1-Year Est. Return

Physician Wealth Advisors's SANA Position: Q2 2026 in Review

Physician Wealth Advisors held its Sana Biotechnology (SANA) position steady in Q2 2026 at 975 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1271.

Physician Wealth Advisors first reported a position in SANA in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.97K in Q4 2025. 49 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Physician Wealth Advisors held 975 shares of Sana Biotechnology worth $3.4K as of Q2 2026.
Physician Wealth Advisors left its Sana Biotechnology share count unchanged in Q2 2026.
Sana Biotechnology made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1271 holding.
Physician Wealth Advisors first reported a position in Sana Biotechnology in Q4 2024 and has held it in 7 quarters since.
Physician Wealth Advisors's Sana Biotechnology position peaked at $3.97K in Q4 2025.
49 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.